publications

ACB’s objection to commodity clearance of Corteva’s MON 89034 x TC1507 x MIR16

ACB’s Objection to Monsanto’s Application for Commodity Import of GM maize for a number of events: herbicide tolerance, including for dicamba, as well as pest resistance -

MON 87427 x MON 89034 x MIR 162 x MON87419;

Objection against general release of three 2,4-D GM maize varieties:

The ACB has played an essential watch-dog role on new GMO permits in South Africa for a decade now, adding substantially to the discourse about the scientific assessment of GMOs as well as about issues of socioeconomic impacts and democratic decisionmaking, through lodging substantive comments on at least 30 permit applications.

ACB is objecting to the commodity clearance of the triple-stacked GM soybean event MON 87708 x MON 89788 x A5547-127, due to concerns surrounding the lack of safety assessment data for this crop and the known toxicity of the three pesticides it is designed to tolerate.

The Tanzania National Farmers Network Organisation, Mtandao wa Vikundi vya Wakulima Tanzania (MVIWATA) and the African Centre for Biodiversity (ACB) are objecting to an application submitted by the Tanzania Commission for Science and Technology (COSTECH) for confined field trials of Monsanto’s stacked GM maize MON 87460 X MON 810 (GM drought tol

In this objection, ACB raises numerous concerns with the application by Monsanto for the commercial release of the triple stacked event.

Supported by: More than 25 000 people who signed a Care2 “#VoteNoToGMO!" Petition. We Say No to Monsanto Petition by 25 000 people who signed a Care2 “#VoteNoToGMO!” Petition.

South Africa is in the grip of the worst drought since 1992, with many parts of the country experiencing record temperatures and little to no rain.

The African Centre for Biodiversity (ACB) has on 7th August 2015, lodged an appeal to Agriculture, Water Affairs and Forestry Minister Senzeni Zokwana, against the general release approval of Monsanto’s genetically modified (GM) maize, MON87460 granted by the Executive Council (EC): GMO Act.

This submission by Monsanto makes a joke of biosafety risk assessment in that it is not based on the actual event under consideration, but rather, the applicant posits claim of lack of harm, toxicity, and allergenicity based on data carried out on other lines containing the same transgene/event.

The ACB has submitted an objection to an application by Dow Agro-sciences to conduct a field trial of the stacked GM maize event MON 89034 x TC 1507 x MON NK603.

The Africa Centre for Biosafety (ACB), supported by Food & Water Europe and the Gaia Foundation, today wrote to UK Ministers for International Development, Business and Environment asking for evidence for the basis of UK

Field trials with MON 87460 are currently underway in South Africa at Hopetown, Orania, Pretoria, Lutzville and Delareyville.

This is ACB's objection to the application by Dow Chemicals for approval for import into SA of its GM soyabean 2,4 D and glufosinate ammonium (DAS-68416-4).

This is the non CBI version of the application submitted by Dow Chemicals to the SA GMO authorities for approval of its GM soybeans, 2,4 for importation into SA.

In 2007 Monsanto was granted a trial release permit to conduct field trials for its 'drought tolerant' maize event MON8746.

Pioneer Hi-Bred, who are currently attempting to acquire South Africa's largest remaining seed company, Pannar Seed, have submitted applications for field trials of four

The ACB hereby lodges its objections and comments to the draft regulations regarding the mandatory blending of biofuels with petrol and diesel.

In this paper, the ACB sets out its objections to ARC's appeal against the decision by the Executive Council: GMO Act, refusing ARC's application for the commercial release of